From the Newsroom| Fourth Ranbaxy plant under FDA scrutiny

Name: From the Newsroom| Fourth Ranbaxy plant under FDA scrutiny
Uploaded: 2018-02-16T15:50:11+00:00
Duration: 3 min 58 s
Channel: Mint
Description: Mint's CH Unnikrishnan talks about the trouble drug maker Ranbaxy is facing with the US regulator.

Mint

Mint's CH Unnikrishnan talks about the trouble drug maker Ranbaxy is facing with the US regulator.

Category

Comments

Recommended